Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: The Clinics: Internal Medicine, cartea 35-4
Editat de Jennifer R. Brown?en Limba Engleză Hardback – 14 iul 2021
Din seria The Clinics: Internal Medicine
- 70% Preț: 171.46 lei
- 70% Preț: 185.63 lei
- 18% Preț: 348.03 lei
- 18% Preț: 472.22 lei
- 18% Preț: 472.52 lei
- 18% Preț: 447.46 lei
- 5% Preț: 518.61 lei
- 5% Preț: 518.66 lei
- 5% Preț: 518.95 lei
- 5% Preț: 519.42 lei
- 5% Preț: 517.95 lei
- 5% Preț: 519.59 lei
- 5% Preț: 573.60 lei
- 5% Preț: 403.10 lei
- 5% Preț: 402.76 lei
- 18% Preț: 243.98 lei
- 5% Preț: 403.03 lei
- 18% Preț: 334.91 lei
- 5% Preț: 402.95 lei
- 5% Preț: 463.34 lei
- 5% Preț: 460.59 lei
- 5% Preț: 403.43 lei
- 5% Preț: 405.52 lei
- 5% Preț: 402.76 lei
- 5% Preț: 460.68 lei
- 18% Preț: 399.26 lei
- 5% Preț: 460.15 lei
- 5% Preț: 448.59 lei
- 5% Preț: 506.69 lei
- 5% Preț: 402.07 lei
- 5% Preț: 402.51 lei
- 5% Preț: 402.51 lei
- 5% Preț: 519.14 lei
- 5% Preț: 518.37 lei
- 5% Preț: 596.51 lei
- 5% Preț: 518.20 lei
- 5% Preț: 518.08 lei
- 21% Preț: 447.44 lei
- 22% Preț: 446.08 lei
- 5% Preț: 576.43 lei
- 5% Preț: 576.16 lei
- 5% Preț: 577.91 lei
- 5% Preț: 576.93 lei
- 5% Preț: 570.06 lei
- 5% Preț: 576.10 lei
- 5% Preț: 686.23 lei
- 18% Preț: 472.51 lei
- 5% Preț: 713.59 lei
- 5% Preț: 576.26 lei
- 5% Preț: 579.20 lei
Preț: 524.18 lei
Preț vechi: 551.76 lei
-5% Nou
Puncte Express: 786
Preț estimativ în valută:
100.31€ • 105.51$ • 83.56£
100.31€ • 105.51$ • 83.56£
Carte tipărită la comandă
Livrare economică 28 decembrie 24 - 11 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323896924
ISBN-10: 0323896928
Pagini: 240
Dimensiuni: 152 x 229 mm
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323896928
Pagini: 240
Dimensiuni: 152 x 229 mm
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic LeukemiaThe Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical ImplicationsPrognostic and Predictive Implications of Cytogenetics and GenomicsGenomics of Resistance to Targeted TherapiesFirst-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and BeyondBruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond IbrutinibShould Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton's Tyrosine Kinase InhibitorsThe Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic LeukemiaCan Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?Immune Therapy for Chronic Lymphocytic Leukemia: Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond